Kháng nguyên tái tổ hợp ORF66 và ORFK12 để phát hiện kháng thể đối với virus herpes ở người type 8 ở bệnh nhân dương tính và âm tính với HIV

Ablashi DV, Chatlynne LG, Whitman JE, Cesarman E (2002) Spectrum of Kaposi’s sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev 15:439–464 Andre S, Schatz O, Bogner JR, Zeichhardt H, Stoffler MM, Jahn HU, Ullrich R, Sonntag AK, Kehm R, Haas J (1997) Detection of antibodies against viral capsid proteins of human herpesvirus 8 in AIDS-associated Kaposi’s sarcoma. J Mol Med 75:145–152 Cannon MJ, Dollard SC, Smith DK, Klein RS, Schuman P, Rich JD, Vlahov D, Pellett PE, HIV Epidemiology Research Study Group (2001) Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. New Engl J Med 344:637–643 Caterino-de-Araujo A, Magri MC, Santos-Fortuna E, Souza JF, Sens YA, Jabur P (2007) Human herpesvirus-8 infection in hemodialysis patients from São Paulo, Brazil: preliminary results. Transplant Proc 39:3044–3046 Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 265:1865–1869 Gambus G, Bourboulia D, Esteve A, Lahoz R, Rodriguez C, Bolao F (2001) Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain. AIDS 15:1167–1174 Gandy SZ, Linnstaedt SD, Muralidhar S, Cashman KA, Rosenthal LJ, Casey JL (2007) RNA editing of the HHV-8 Kaposin transcript eliminates its transforming activity and is induced during lytic replication. J Virol 81:13544–13551 Goedert JJ, Charurat M, Blattner WA, Hershow RC, Pitt J, Diaz C, Mofenson LM, Green K, Minkoff H, Paul ME, Thomas DL, Whitby D (2003) Risk factors for Kaposi’s sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA. AIDS 17:425–433 Guttman-Yassky E, Dubnov J, Kra-Oz Z, Friedman-Birnbaum R, Silbermann M, Barchana M, Bergman R, Sarid R (2006) Classic Kaposi sarcoma. Which KSHV-seropositive individuals are at risk? Cancer 106:413–419 Hladik W, Dollard SC, Downing RG, Kataaha P, Pellett PE, Karon JM (2003) Kaposi’s sarcoma in Uganda: risk factors for human herpesvirus 8 infection among blood donors. J Acquir Immune Defic Syndr 33:206–210 Huang LM, Huang SY, Chen MY, Chao MF, Lu CY, Tien HF, Lee CY, Jeang KT (2000) Geographical differences in human herpesvirus 8 seroepidemiology: a survey of 1,201 individuals in Asia. J Med Virol 60:290–293 Inoue N, Mar EC, Dollard SC, Pau CP, Zheng Q, Pellett PE (2000) New immunofluorescence assays for detection of Human herpesvirus 8-specific antibodies. Clin Diagn Lab Immunol 7:427–435 Katano H, Iwasaki T, Baba N, Terai M, Mori S, Iwamoto A, Kurata T, Sata T (2000) Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi’s sarcoma. J Virol 74:3478–3485 Kliche S, Nagel W, Kremmer E, Atzler C, Ege A, Knorr T, Koszinowski U, Kolanus W, Haas J (2001) Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1. Mol Cell 7:833–843 Lang D, Hinderer W, Rothe M, Sonneborn HH, Neipel F, Raab M, Rabenau H, Masquelier B, Fleury H (1999) Comparison of the immunoglobulin-G-specific seroreactivity of different recombinant antigens of the human herpesvirus 8. Virology 260:47–54 Lee CH, Chang HW, Wang IK, Lin CL, Chen TC, Wang PH, Chang HY, Chen JB, Hsu KT, Chuang FR (2004) Diabetes mellitus, hyperhomocystinemia and atherosclerotic vascular disease in Taiwanese chronic hemodialysis patients: a retrospective study. Ren Fail 26:317–323 Li M, MacKey J, Czajak SC, Desrosiers RC, Lackner AA, Jung JU (1999) Identification and characterization of Kaposi’s sarcoma-associated herpesvirus K8.1 virion glycoprotein. J Virol 73:1341–1349 Lin SF, Sun R, Heston L, Gradoville L, Shedd D, Haglund K, Rigsby M, Miller G (1997) Identification, expression, and immunogenicity of Kaposi’s sarcoma-associated herpesvirus-encoded small viral capsid antigen. J Virol 71:3069–3076 Lin CW, Tu PF, Hsiao NW, Chang CY, Wan L, Lin YT, Chang HW (2007) Identification of a novel septin 4 protein binding to human herpesvirus 8 kaposin A protein using a phage display cDNA library. J Virol Methods 143:65–72 Lin CW, Chang CP, Wu FY, Liu CL (2008) Comparative prevalence of plasma human herpesvirus 8 DNA in sexual contact and intravenous injection routes of HIV transmission. FEMS Immunol Med Microbiol 52:428–430 Nalesnik MA (1999) Epstein-Barr virus. In: Lennette EH, Smith TF (eds) Laboratory diagnosis of viral infections. Marcel Dekker, Inc., New York, pp 385–419 Olsen SJ, Sarid R, Chang Y, Moore PS (2000) Evaluation of the latency-associated nuclear antigen (ORF73) of Kaposi’s sarcoma-associated herpesvirus by peptide mapping and bacterially expressed recombinant western blot assay. J Infect Dis 182:306–310 Panayiotakopoulos GD, Mavroyianni D, Politou M, Aroni K, Kosmopoulou O, Kontos AN (2005) Human herpesvirus-8 seropositivity and clinical correlations in HIV-1-positive and highly exposed, persistently HIV-seronegative individuals in Greece. AIDS Patient Care STDS 19:375–383 Pau CP, Lam LL, Spira TJ, Black JB, Stewart JA, Pellett PE, Respess RA (1998) Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol 36:1574–1577 Paulose-Murphy M, Ha NK, Xiang C, Chen Y, Gillim L, Yarchoan R, Meltzer P, Bittner M, Trent J, Zeichner S (2001) Transcription program of human herpesvirus 8 (kaposi’s sarcoma-associated herpesvirus). J Virol 75:4843–4853 Raab MS, Albrecht JC, Birkmann A, Yaguboglu S, Lang D, Fleckenstein B, Neipel F (1998) The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J Virol 72:6725–6731 Sadler R, Wu L, Forghani B, Renne R, Zhong W, Herndier B, Ganem D (1999) A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi’s sarcoma-associated herpesvirus. J Virol 73:5722–5730 Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS (1998) Transcription mapping of the Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 72:1005–1012 Schulz TF (2006) The pleiotropic effects of Kaposi’s sarcoma herpesvirus. J Pathol 208:187–198 Shedd D, Angeloni A, Niederman J, Miller G (1995) Detection of human serum antibodies to the BFRF3 Epstein-Barr virus capsid component by means of a DNA-binding assay. J Infect Dis 172:1367–1370 Simo R, Hernandez C, Genesca J, Jardi R, Mesa J (1996) High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 19:998–1000 Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IV, Weiss RA, Moore PS (1996) Prevalence of Kaposi’s sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348:1133–1138 Tedeschi R, Enbom M, Bidoli E, Linde A, De Paoli P, Dillner J (2001) Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi’s sarcoma. J Clin Microbiol 39:4269–4273 Tsai WS, Chang MH, Chen JY, Lee CY, Liu YG (1989) Seroepidemiological study of Epstein-Barr virus infection in children in Taipei. J Microbiol Immunol Infect 30:81–86 van Grunsven WMJ, van Heerde EC, de Haard HJW, Spaan WJM, Middeldorp JM (1993) Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins. J Virol 67:3908–3916 Wang YF, Lee SB, Cheng LC, Tai MH, Su IJ (2002) Detection of serum antibodies to three different recombinant antigens of human herpesvirus 8 by immunoblotting: seroprevalence studies in Taiwan. Clin Chim Acta 320:37–42 Weissmann A, Linn S, Weltfriend S, Friedman-Birnbaum R (2000) Epidemiological study of classic Kaposi’s sarcoma: a retrospective review of 125 cases from Northern Israel. J Eur Acad Dermatol Venereol 14:91–95